Document 2263
 DOCN  M94A2263
 TI    Evaluation of a prevention indicator in prenatal clinics in Brazil.
 DT    9412
 AU    Perini N; Pinheiro M; Bernardo E; Oliveira D; Paranhos N; Loures L;
       Lauria L; Health Department of Federal District, Brasilia, DF, Brazil.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):344 (abstract no. PC0312). Unique
       Identifier : AIDSLINE ICA10/94370312
 AB    OBJECTIVES: Indicators (Priority Prevention Indicators, PPIs) for
       monitoring National AIDS Programs (NAP) were developed by GPA/WHO. PPI-5
       (HIV seroprevalence in pregnant women, 15-24 years, attending prenatal
       clinics, non-linked) was field tested by the Brasilia Public Health
       System (BPHS), in collaboration with the National STD/AIDS Control
       Programme, Brazil. METHODS: After identifying all BPHS prenatal clinics
       (49), the participating Centers were selected by systematic sampling,
       based on the number of pregnant women seen at each Center. From each
       enrolled Clinic, 75 samples were to be collected (a total of 1500). All
       pregnant women in their first clinic visit had their age and parity
       recorded. A blood sample was collected in two types of filter paper
       (Whatman 4 and Mellita coffee filter); a serum sample was also obtained
       to be used as a gold-standard. RESULTS: The main problems identified in
       implementing PPI-5 within the routine of the BPHS prenatal program were:
       (1) the need to prepare a document to all participant Centers,
       describing, in general terms, the PPI objectives and specifying the
       tasks and responsibilities of each Center within the evaluation; (2) the
       need of involving the Directors of the participating Centers since the
       planning stage. Although they did not interfere with the data
       collection, they did not considered themselves as part of the PPI; (3)
       the need to establish a formal training period for those involved with
       data collection, including the eventual replacements (vacations, leave
       of absence, etc.); (4) the need to develop forms to be used by all
       participating Centers; the participation of the Center personnel in this
       stage is mandatory and (5) the need to involve the PPI supervision with
       the Centers routine problems; in one participating Clinic, the data
       collection was suspended because pregnancy tests were not available.
       CONCLUSIONS: The inclusion of PPI-5 in the routine of prenatal clinics
       in the BPHS have shown the feasibility of carrying out these indicators
       to monitor NAPs. The problems identified are easily solved by an
       adequate planning phase and a closer contact between the PPI supervision
       and the participating Centers leadership.
 DE    Adolescence  Adult  Brazil/EPIDEMIOLOGY  *Developing Countries
       Feasibility Studies  Female  *Health Education  Health Priorities  Human
       HIV Infections/EPIDEMIOLOGY/*PREVENTION & CONTROL/TRANSMISSION  HIV
       Seroprevalence/*TRENDS  Infant, Newborn  Pregnancy  Pregnancy
       Complications, Infectious/EPIDEMIOLOGY/ETIOLOGY/  *PREVENTION & CONTROL
       *Prenatal Care  Program Evaluation  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).